Skip to main content
Top
Published in: European Radiology 12/2019

01-12-2019 | Computed Tomography

Liver CT perfusion: which is the relevant delay that reduces radiation dose and maintains diagnostic accuracy?

Authors: Alessandro Bevilacqua, Silvia Malavasi, Valérie Vilgrain

Published in: European Radiology | Issue 12/2019

Login to get access

Abstract

Objectives

High radiation dose during CT perfusion (CTp) studies contributes to prevent CTp application in daily clinical practice. This work evaluates the consequences of scan delay on perfusion parameters and provides guidelines to help reducing the radiation dose by choosing the most appropriate delay.

Methods

Fifty-nine patients (34 men, 25 women; mean age 68 ± 12) with colorectal cancer, without underlying liver disease, underwent liver CTp, with the acquisition starting simultaneously with iodinated contrast agent injection. Blood flow (BF) and hepatic perfusion index (HPI) were computed on the acquired examinations and compared with those of the same examinations when a variable scan delay (τ) is introduced. Dose length product, CT dose index, and effective dose were also computed on original and delayed examinations.

Results

Altogether, three groups of delays (τ ≤ 4 s, 5 s ≤ τ ≤ 9 s, τ ≥ 10 s) were identified, yielding increasing radiation dose saving (RDS) (RDS ≤ 9.5%, 11.9% ≤ RDS ≤ 21.4%, RDS ≥ 23.8%) and decreasing perfusion accuracy (high (τ ≤ 4 s), medium (5 s ≤ τ ≤ 9 s), low (τ ≥ 10 s)). In particular, single-input and arterial BF and HPI were more insensitive to delay as regards the absolute variations (only 1 ml/min/100 g and 1%, respectively, for τ ≤ 9 s), than portal and total BF.

Conclusion

Using delays lower than 4 s does not change perfusion accuracy and conveys unnecessary dose to patients. Conversely, starting the acquisition 9 s after contrast agent injection yields a RDS of about 21%, with no significant losses in perfusion accuracy.

Key Points

• Scan delays lower than 4 s do not alter perfusion accuracy and deliver an unnecessary radiation dose to patients.
• Radiation dose delivered to patients can be reduced by 21.4% by introducing a 9-s scan delay, while keeping accurate perfusion values.
• Using scan delays higher than 10 s, some perfusion parameters (portal and total BF) were inaccurate.
Appendix
Available only for authorised users
Literature
1.
go back to reference Oğul H, Kantarcı M, Genç B et al (2014) Perfusion CT imaging of the liver: review of clinical applications. Diagn Interv Radiol 20:379–389CrossRef Oğul H, Kantarcı M, Genç B et al (2014) Perfusion CT imaging of the liver: review of clinical applications. Diagn Interv Radiol 20:379–389CrossRef
2.
go back to reference Kartalis N, Brehmer K, Loizou L (2017) Multi-detector CT: liver protocol and recent developments. Eur J Radiol 97:101–109CrossRef Kartalis N, Brehmer K, Loizou L (2017) Multi-detector CT: liver protocol and recent developments. Eur J Radiol 97:101–109CrossRef
3.
go back to reference Kim SH, Kamaya A, Willmann JK (2014) CT perfusion of the liver: principles and applications in oncology. Radiology 272:322–344CrossRef Kim SH, Kamaya A, Willmann JK (2014) CT perfusion of the liver: principles and applications in oncology. Radiology 272:322–344CrossRef
4.
go back to reference Ippolito D, Querques G, Okolicsanyi S et al (2018) Dynamic contrast enhanced perfusion CT imaging: a diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions. Eur J Radiol 106:62–68CrossRef Ippolito D, Querques G, Okolicsanyi S et al (2018) Dynamic contrast enhanced perfusion CT imaging: a diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions. Eur J Radiol 106:62–68CrossRef
5.
go back to reference Nakamura Y, Kawaoka T, Higaki T et al (2018) Hepatocellular carcinoma treated with sorafenib: arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival. Eur J Radiol 98:41–49CrossRef Nakamura Y, Kawaoka T, Higaki T et al (2018) Hepatocellular carcinoma treated with sorafenib: arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival. Eur J Radiol 98:41–49CrossRef
6.
go back to reference Horowitz JM, Venkatesh SK, Ehman RL et al (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42:2037–2053CrossRef Horowitz JM, Venkatesh SK, Ehman RL et al (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42:2037–2053CrossRef
8.
go back to reference De Robertis R, D’Onofrio M, Demozzi E, Crosara S, Canestrini S, Pozzi Mucelli R (2014) Noninvasive diagnosis of cirrhosis: a review of different imaging modalities. World J Gastroenterol 20:7231–7241CrossRef De Robertis R, D’Onofrio M, Demozzi E, Crosara S, Canestrini S, Pozzi Mucelli R (2014) Noninvasive diagnosis of cirrhosis: a review of different imaging modalities. World J Gastroenterol 20:7231–7241CrossRef
9.
go back to reference Fischer MA, Marquez HP, Gordic S et al (2017) Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma. Eur Radiol 27:1074–1080CrossRef Fischer MA, Marquez HP, Gordic S et al (2017) Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma. Eur Radiol 27:1074–1080CrossRef
10.
go back to reference Marquez HP, Karalli A, Haubenreisser H et al (2017) Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma. Eur J Radiol 91:160–167CrossRef Marquez HP, Karalli A, Haubenreisser H et al (2017) Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma. Eur J Radiol 91:160–167CrossRef
11.
go back to reference Fischer MA, Kartalis N, Grigoriadis A et al (2015) Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis. Eur Radiol 25:3123–3132CrossRef Fischer MA, Kartalis N, Grigoriadis A et al (2015) Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis. Eur Radiol 25:3123–3132CrossRef
12.
go back to reference Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S (2017) Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: a feasibility study. Eur J Radiol 90:34–41CrossRef Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S (2017) Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: a feasibility study. Eur J Radiol 90:34–41CrossRef
13.
go back to reference Perisinakis K, Tzedakis A, Pouli S, Spanakis K, Hatzidakis A, Damilakis J (2019) Comparison of patient dose from routine multi-phase and dynamic liver perfusion CT studies taking into account the effect of iodinated contrast administration. Eur J Radiol 110:39–44CrossRef Perisinakis K, Tzedakis A, Pouli S, Spanakis K, Hatzidakis A, Damilakis J (2019) Comparison of patient dose from routine multi-phase and dynamic liver perfusion CT studies taking into account the effect of iodinated contrast administration. Eur J Radiol 110:39–44CrossRef
14.
go back to reference Marquez HP, Puippe G, Mathew RP, Alkadhi H, Pfammatter T, Fischer MA (2017) CT perfusion for early response evaluation of radiofrequency ablation of focal liver lesions: first experience. Cardiovasc Intervent Radiol 40:90–98CrossRef Marquez HP, Puippe G, Mathew RP, Alkadhi H, Pfammatter T, Fischer MA (2017) CT perfusion for early response evaluation of radiofrequency ablation of focal liver lesions: first experience. Cardiovasc Intervent Radiol 40:90–98CrossRef
15.
go back to reference Kalra MK, Sodickson AD, Mayo-Smith WW (2015) CT radiation: key concepts for gentle and wise use. Radiographics 35:1706–1721CrossRef Kalra MK, Sodickson AD, Mayo-Smith WW (2015) CT radiation: key concepts for gentle and wise use. Radiographics 35:1706–1721CrossRef
16.
go back to reference Lell MM, Wildberger JE, Alkadhi H, Damilakis J, Kachelriess M (2015) Evolution in computed tomography: the battle for speed and dose. Invest Radiol 50:629–644CrossRef Lell MM, Wildberger JE, Alkadhi H, Damilakis J, Kachelriess M (2015) Evolution in computed tomography: the battle for speed and dose. Invest Radiol 50:629–644CrossRef
17.
go back to reference Ramirez-Giraldo JC, Thompson SM, Krishnamurthi G et al (2013) Evaluation of strategies to reduce radiation dose in perfusion CT imaging using a reproducible biologic phantom. AJR Am J Roentgenol 200:W621–W627CrossRef Ramirez-Giraldo JC, Thompson SM, Krishnamurthi G et al (2013) Evaluation of strategies to reduce radiation dose in perfusion CT imaging using a reproducible biologic phantom. AJR Am J Roentgenol 200:W621–W627CrossRef
18.
go back to reference Ng CS, Hobbs BP, Chandler AG et al (2013) Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values. Radiology 269:758–767CrossRef Ng CS, Hobbs BP, Chandler AG et al (2013) Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values. Radiology 269:758–767CrossRef
19.
go back to reference Ng CS, Chandler AG, Yao JC et al (2014) Effect of pre-enhancement set-point on CT perfusion values in normal liver and metastases to the liver from neuroendocrine tumors. J Comput Assist Tomogr 38:526–534CrossRef Ng CS, Chandler AG, Yao JC et al (2014) Effect of pre-enhancement set-point on CT perfusion values in normal liver and metastases to the liver from neuroendocrine tumors. J Comput Assist Tomogr 38:526–534CrossRef
20.
go back to reference Lee DH, Lee JM, Klotz E, Han JK (2016) Multiphasic dynamic computed tomography evaluation of liver tissue perfusion characteristics using the dual maximum slope model in patients with cirrhosis and hepatocellular carcinoma: a feasibility study. Invest Radiol 51:430–434CrossRef Lee DH, Lee JM, Klotz E, Han JK (2016) Multiphasic dynamic computed tomography evaluation of liver tissue perfusion characteristics using the dual maximum slope model in patients with cirrhosis and hepatocellular carcinoma: a feasibility study. Invest Radiol 51:430–434CrossRef
21.
go back to reference Fischer MA, Brehmer K, Svensson A, Aspelin P, Brismar TB (2016) Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension. Eur Radiol 26:4030–4036CrossRef Fischer MA, Brehmer K, Svensson A, Aspelin P, Brismar TB (2016) Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension. Eur Radiol 26:4030–4036CrossRef
22.
go back to reference Kako Y, Yamakado K, Jomoto W et al (2017) Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt. Jpn J Radiol 35:366–372CrossRef Kako Y, Yamakado K, Jomoto W et al (2017) Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt. Jpn J Radiol 35:366–372CrossRef
23.
go back to reference Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV (2012) Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol 47:11–17CrossRef Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV (2012) Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol 47:11–17CrossRef
24.
go back to reference Tamandl D, Waneck F, Sieghart W et al (2017) Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease control. Eur J Radiol 90:73–80CrossRef Tamandl D, Waneck F, Sieghart W et al (2017) Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease control. Eur J Radiol 90:73–80CrossRef
26.
go back to reference Mulé S, Pigneur F, Quelever R et al (2018) Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma? Eur Radiol 28:1977–1985CrossRef Mulé S, Pigneur F, Quelever R et al (2018) Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma? Eur Radiol 28:1977–1985CrossRef
27.
go back to reference Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405–411CrossRef Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405–411CrossRef
28.
go back to reference Bevilacqua A, Barone D, Malavasi S, Gavelli G (2014) Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion. Acad Radiol 21:1416–1426CrossRef Bevilacqua A, Barone D, Malavasi S, Gavelli G (2014) Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion. Acad Radiol 21:1416–1426CrossRef
29.
go back to reference Gibaldi A, Barone D, Gavelli G, Malavasi S, Bevilacqua A (2015) Effects of guided random sampling of TCCs on blood flow values in CT perfusion studies of lung tumors. Acad Radiol 22:58–69CrossRef Gibaldi A, Barone D, Gavelli G, Malavasi S, Bevilacqua A (2015) Effects of guided random sampling of TCCs on blood flow values in CT perfusion studies of lung tumors. Acad Radiol 22:58–69CrossRef
30.
go back to reference Blomley MJ, Coulden R, Dawson P et al (1995) Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19:424–433CrossRef Blomley MJ, Coulden R, Dawson P et al (1995) Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19:424–433CrossRef
32.
go back to reference Malavasi S, Barone D, Gavelli G, Bevilacqua A (2017) Multislice analysis of blood flow values in CT perfusion studies of lung cancer. Biomed Res Int 2017:3236893CrossRef Malavasi S, Barone D, Gavelli G, Bevilacqua A (2017) Multislice analysis of blood flow values in CT perfusion studies of lung cancer. Biomed Res Int 2017:3236893CrossRef
Metadata
Title
Liver CT perfusion: which is the relevant delay that reduces radiation dose and maintains diagnostic accuracy?
Authors
Alessandro Bevilacqua
Silvia Malavasi
Valérie Vilgrain
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 12/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06259-9

Other articles of this Issue 12/2019

European Radiology 12/2019 Go to the issue